Rocket One Inc. Common Stock (NASDAQ:RKTO) Cut to “Strong Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Rocket One Inc. Common Stock (NASDAQ:RKTO) from a sell rating to a strong sell rating in a research report report published on Saturday morning.

RKTO has been the subject of several other reports. D. Boral Capital reiterated a “buy” rating and set a $5.00 target price on shares of Rocket One Inc. Common Stock in a research note on Wednesday, March 25th. Weiss Ratings upgraded shares of Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, June 23rd. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $5.00.

Rocket One Inc. Common Stock Stock Performance

NASDAQ:RKTO opened at $0.83 on Friday. Rocket One Inc. Common Stock has a one year low of $0.49 and a one year high of $2.45. The business’s 50-day simple moving average is $1.04 and its 200 day simple moving average is $0.95. The stock has a market cap of $18.59 million, a price-to-earnings ratio of -1.04 and a beta of 0.93.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03).

Institutional Trading of Rocket One Inc. Common Stock

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC lifted its holdings in Rocket One Inc. Common Stock by 8.0% during the 2nd quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock worth $143,000 after buying an additional 9,071 shares during the last quarter. Lido Advisors LLC acquired a new position in shares of Rocket One Inc. Common Stock in the 3rd quarter worth approximately $32,000. Kestra Private Wealth Services LLC bought a new stake in shares of Rocket One Inc. Common Stock in the 3rd quarter valued at approximately $51,000. Virtu Financial LLC acquired a new stake in shares of Rocket One Inc. Common Stock during the 3rd quarter valued at approximately $184,000. Finally, Citadel Advisors LLC acquired a new stake in shares of Rocket One Inc. Common Stock during the 3rd quarter valued at approximately $232,000. 7.08% of the stock is owned by institutional investors.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.